Quest Diagnostics Incorporated

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:02 2024-04-19 pm EDT			5-day change	1st Jan Change
128.4 ^USD	+2.01%		-0.16%	-6.85%

Apr. 11	John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission	CI
Apr. 05	Quest Diagnostics Receives Shareholder Proposal from John Chevedden	CI

QUEST DIAGNOSTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations See page 63 . (form 10-K)

February 22, 2021 at 04:17 pm EST

--------------------------------------------------------------------------------

Table of Contents

Latest news about Quest Diagnostics Incorporated

John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission	Apr. 11	CI
Quest Diagnostics Receives Shareholder Proposal from John Chevedden	Apr. 05	CI
Quest Collaborating With Broad Clinical Labs to Assess Whole Genome Sequencing Test for Developmental Delay Disorders	Apr. 02	MT
Quest Diagnostics Receives Shareholder Proposal from John Chevedden	Mar. 25	CI
Transcript : Quest Diagnostics Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 10:15 AM	Mar. 13
Quest Diagnostics Insider Sold Shares Worth $852,769, According to a Recent SEC Filing	Mar. 01	MT
Leerink Partners Starts Quest Diagnostics With Market Perform Rating, $135 Price Target	Feb. 26	MT
Quest Diagnostics Incorporated acquired Assets from Lenco Diagnostic Laboratories Inc. for approximately $110 million.	Feb. 21	CI
Quest Diagnostics' Pack Health, Instacart to Combine Grocery Delivery With Nutrition Coaching Services	Feb. 21	MT
The fate of the market depends on this	Feb. 21
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....	Feb. 21
Correction: Quest Diagnostics Participates in Freenome's $254 Million Financing	Feb. 15	MT
Quest Diagnostics Participates in Freenome's $254 Million Financing	Feb. 15	MT
Freenome Holdings, Inc. announced that it has received $254 million in funding from a group of investors	Feb. 14	CI
Quest Diagnostics Incorporated Announces the Launch of MelaNodal Predict	Feb. 13	CI
Quest Diagnostics Incorporated Announces the Availability of the First Consumer-Initiated, Physician-Ordered Blood-Draw Test for PFAS Chemicals	Feb. 12	CI
Jefferies Upgrades Quest Diagnostics to Buy From Hold, Adjusts Price Target to $155 From $140	Feb. 07	MT
Fed officials fail to convince investors, who are focused on earnings	Feb. 07
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile...	Feb. 07
Deutsche Bank Adjusts Quest Diagnostics Price Target to $125 From $140, Maintains Hold Rating	Feb. 02	MT
Quest Diagnostics' Q4 Adjusted Earnings Increase, Revenue Declines; Issues 2024 Outlook; Raises Dividend	Feb. 01	MT
Transcript : Quest Diagnostics Incorporated, Q4 2023 Earnings Call, Feb 01, 2024	Feb. 01
(DGX) QUEST DIAGNOSTICS Sees Fiscal Year 2024 Revenue Range $9.35B - $9.45B	Feb. 01	MT
(DGX) QUEST DIAGNOSTICS Sees Fiscal Year 2024 EPS Range $8.60 - $8.90	Feb. 01	MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Reports Q4 Revenue $2.29B, vs. Street Est of $2.25B	Feb. 01	MT

Chart Quest Diagnostics Incorporated

Duration

Period

More charts

Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (2.7%).

Sector

Healthcare Facilities & Services

Calendar

2024-04-23 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Quest Diagnostics Incorporated

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

125.9 USD

Average target price

142.3 USD

Spread / Average Target

+13.01%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
QUEST DIAGNOSTICS INCORPORATED	-6.85%	13.98B
CVS HEALTH CORPORATION	-11.66%	87.46B
HCA HEALTHCARE, INC.	+12.72%	78.56B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.85%	29.37B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-11.36%	16.78B
FRESENIUS SE & CO. KGAA	-4.17%	16.01B
EUROFINS SCIENTIFIC SE	+0.92%	12.31B
PURE HEALTH HOLDING	-30.35%	12.07B
DAVITA INC.	+22.01%	11.06B
SOLVENTUM CORPORATION	0.00%	11.06B

Other Healthcare Facilities & Services

Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Healthcare Facilities & Services

QUEST DIAGNOSTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations See page 63 . (form 10-K)

Latest news about Quest Diagnostics Incorporated

Chart Quest Diagnostics Incorporated

Company Profile

Income Statement Evolution

Ratings for Quest Diagnostics Incorporated

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Healthcare Facilities & Services